Citation Impact

Citing Papers

Zygomycetes in Human Disease
2000 Standout
Microbiota in health and diseases
2022 Standout
Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
2014
Oxidative stress, aging, and diseases
2018 Standout
Iron Chelation Decreases NF- k B and HIV Type 1 Activation due to Oxidative Stress
1995
Microbial tryptophan catabolites in health and disease
2018 Standout
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
2004
Albumin–drug interaction and its clinical implication
2013 Standout
Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status
2007
Inconsistency of Reported Uremic Toxin Concentrations
2007
Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants
1992
SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and Catalysis
2012 StandoutNobel
GABAA Receptor Channels
1994 Standout
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
1993
Chronic kidney disease
2011 Standout
A qualitative process system for modeling NF-κB and AP-1 gene regulation in immune cell biology research
1999 StandoutNobel
Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of rhizopus microsporus
1994
Nitric oxide deficiency in chronic kidney disease
2007
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
2002
Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration
2003
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins
2011
In vitro formation of advanced glycation end products in peritoneal dialysis fluid
1995
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
A Comparison of On-Line Hemodiafiltration and High-Flux Hemodialysis
2000
Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture
1990
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Arginase I deficiency: Severe infantile presentation with hyperammonemia: More common than reported?
2011
Chemistry and biology of siderophores
2010 Standout
Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation
2010
Metabolomic profiling of uremic solutes in CKD patients
2010
Plasma, Urinary, and Erythrocyte Concentrations of Guanidino Compounds in Patients with Chronic Renal Failure
1999
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Zygomycetes in Human Disease
2000 Standout
Mechanisms of Diabetic Complications
2013 Standout
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
2017 Standout
Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes
2004
Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
2017
Creatine Kinase Gene Mutation in a Patient with Muscle Creatine Kinase Deficiency
2001 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout

Works of I. Becaus being referenced

Remarkable Removal of Beta-2-Microglobulin by On-Line Hemodiafiltration
1998
On‐line haemodiafiltration. Remarkable removal of β2‐microglobulin. Long‐term clinical observations
2000
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients
1992
Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency
1997
Guanidino compounds in uraemic dialysed patients
1986
Serum Guanidino Compound Levels and the Influence of a Single Hemodialysis in Uremic Patients Undergoing Maintenance Hemodialysis
1987
Rankless by CCL
2026